Skip to content

Alto Neuroscience ANRO Accrued interest

Accrued interest at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
$2.1M+16.7%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$887.88M+1,358%
Enterprise value$644.49M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:InterestPayableCurrent.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's accrued interest?
Alto Neuroscience (ANRO) reported accrued interest of $115K in Q1 2026.
How has Alto Neuroscience's accrued interest changed year-over-year?
Alto Neuroscience's accrued interest decreased by 25.3% year-over-year, from $154K to $115K.
What is the long-term trend for Alto Neuroscience's accrued interest?
Over 2 years (2023 to 2025), Alto Neuroscience's accrued interest has grown at a 18.5% compound annual growth rate (CAGR), from $84K to $118K.
What does accrued interest mean?
Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.